1989•The Journal of UrologyRequires access

A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors

George J. Bosl, Nancy L. Geller, Dean F. Bajorin, S P Leitner, A Yagoda, Robert B. Golbey, Howard I. Scher, N. J. Vogelzang, James R. Auman, Robert W. Carey, William R. Fair, H.W. Herr, M. Morse, Pramod C. Sogani, Willet F. Whitmore

Open publisher page 3 citations

Abstract

No AccessJournal of Urology1 Jun 1989A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors G.J. Bosl, N.L. Geller, D. Bajorin, S.P. Leitner, A. Yagoda, R.B. Golbey, H. Scher, N.J. Vogelzang, J. Auman, R. Carey, W.R. Fair, H. Herr, M. Morse, P. Sogani, and W. Whitmore G.J. BoslG.J. Bosl More articles by this author , N.L. GellerN.L. Geller More articles by this author , D. BajorinD. Bajorin More articles by this author , S.P. LeitnerS.P. Leitner More articles by this author , A. YagodaA. Yagoda More articles by this author , R.B. GolbeyR.B. Golbey More articles by this author , H. ScherH. Scher More articles by this author , N.J. VogelzangN.J. Vogelzang More articles by this author , J. AumanJ. Auman More articles by this author , R. CareyR. Carey More articles by this author , W.R. FairW.R. Fair More articles by this author , H. HerrH. Herr More articles by this author , M. MorseM. Morse More articles by this author , P. SoganiP. Sogani More articles by this author , and W. WhitmoreW. Whitmore More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)41358-9AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors." The Journal of Urology, 141(6), pp. 1499–1500 © 1989 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 141Issue 6June 1989Page: 1499-1500 Advertisement Copyright & Permissions© 1989 by The American Urological Association Education and Research, Inc.MetricsAuthor Information G.J. Bosl More articles by this author N.L. Geller More articles by this author D. Bajorin More articles by this author S.P. Leitner More articles by this author A. Yagoda More articles by this author R.B. Golbey More articles by this author H. Scher More articles by this author N.J. Vogelzang More articles by this author J. Auman More articles by this author R. Carey More articles by this author W.R. Fair More articles by this author H. Herr More articles by this author M. Morse More articles by this author P. Sogani More articles by this author W. Whitmore More articles by this author Expand All Advertisement PDF downloadLoading ...

About this research paper

What this paper is about

No AccessJournal of Urology1 Jun 1989A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors G.J. Bosl, N.L. Geller, D. Bajorin, S.P. Leitner, A. Yagoda, R.B. Golbey, H. Scher, N.J. Vogelzang, J. Auman, R. Carey, W.R. Fair, H. Herr, M. Morse, P. Sogani, and W. Whitmore G.J. BoslG.J. Bosl More articles by this author , N.L. GellerN.L. Geller More articles by this author , D. BajorinD. Bajorin More articles by this author , S.P. LeitnerS.P. Leitner More articles by this author , A. YagodaA. Yagoda More articles by this author , R.B. GolbeyR.B. Golbey More articles by this author , H. ScherH. Scher More articles by this author , N.J. VogelzangN.J. Vogelzang More articles by this author , J. AumanJ. Auman More articles by this author , R. CareyR. Carey More articles by this author , W.R. FairW.R. Fair More articles by this author , H. HerrH. Herr More articles by this author , M. MorseM. Morse More articles by this author , P. SoganiP. Sogani More articles by this author , and W. WhitmoreW. Whitmore More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)41358-9AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors." The Journal of Urology, 141(6), pp. 1499–1500 © 1989 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 141Issue 6June 1989Page: 1499-1500 Advertisement Copyright & Permissions© 1989 by The American Urological Association Education and Research, Inc.MetricsAuthor Information G.J. Bosl More articles by this author N.L. Geller More articles by this author D. Bajorin More articles by this author S.P. Leitner More articles by this author A. Yagoda More articles by this author R.B. Golbey More articles by this author H. Scher More articles by this author N.J. Vogelzang More articles by this author J. Auman More articles by this author R. Carey More articles by this author W.R. Fair More articles by this author H. Herr More articles by this author M. Morse More articles by this author P. Sogani More articles by this author W. Whitmore More articles by this author Expand All Advertisement PDF downloadLoading ...

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

No AccessJournal of Urology1 Jun 1989A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors G.J. Bosl, N.L. Geller, D. Bajorin, S.P. Leitner, A. Yagoda, R.B. Golbey, H. Scher, N.J. Vogelzang, J. Auman, R. Carey, W.R. Fair, H. Herr, M. Morse, P. Sogani, and W. Whitmore G.J. BoslG.J. Bosl More articles by this author , N.L. GellerN.L. Geller More articles by this author , D. BajorinD. Bajorin More articles by this author , S.P. LeitnerS.P. Leitner More articles by this author , A. YagodaA. Yagoda More articles by this author , R.B. GolbeyR.B. Golbey More articles by this author , H. ScherH. Scher More articles by this author , N.J. VogelzangN.J. Vogelzang More articles by this author , J. AumanJ. Auman More articles by this author , R. CareyR. Carey More articles by this author , W.R. FairW.R. Fair More articles by this author , H. HerrH. Herr More articles by this author , M. MorseM. Morse More articles by this author , P. SoganiP. Sogani More articles by this author , and W. WhitmoreW. Whitmore More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)41358-9AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors." The Journal of Urology, 141(6), pp. 1499–1500 © 1989 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 141Issue 6June 1989Page: 1499-1500 Advertisement Copyright & Permissions© 1989 by The American Urological Association Education and Research, Inc.MetricsAuthor Information G.J. Bosl More articles by this author N.L. Geller More articles by this author D. Bajorin More articles by this author S.P. Leitner More articles by this author A. Yagoda More articles by this author R.B. Golbey More articles by this author H. Scher More articles by this author N.J. Vogelzang More articles by this author J. Auman More articles by this author R. Carey More articles by this author W.R. Fair More articles by this author H. Herr More articles by this author M. Morse More articles by this author P. Sogani More articles by this author W. Whitmore More articles by this author Expand All Advertisement PDF downloadLoading ...

Key concepts: Etoposide, Vinblastine, Medicine, Bleomycin, Cisplatin, Cyclophosphamide, Dactinomycin, Germ cell tumors

Related papers

Back to paper searchBrowse research topicsOriginal source
A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors — Research Paper | ScholarLens